Nebula Research & Development LLC Abbott Laboratories Transaction History

Nebula Research & Development LLC

  • $836 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$100.73 - $112.44 $163,887 - $182,939
1,627 Added 10.46%
17,178 $1.78 Billion
Q1 2024

May 15, 2024
BUY
$109.52 - $120.96 $1.7 Million - $1.88 Million
15,551 New
15,551 $1.77 Billion
Q3 2023

Nov 14, 2023
BUY
$95.53 - $114.62 $952,529 - $1.14 Million
9,971 New
9,971 $966 Million
Q1 2023

May 15, 2023
BUY
$96.86 - $114.01 $215,126 - $253,216
2,221 New
2,221 $225 Million

Others Institutions Holding ABT

# of Institutions
3,185
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email